Drug intelligence / Profile preview

miR-29a-3p mimic

Development stage
Preclinical
Lead developer
Viridian Therapeutics
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Inhalation, Intranasal, Intraperitoneal, Intratumoral
01

Overview

miR-29a-3p mimic is a synthetic, double-stranded RNA oligonucleotide designed to replicate the biological activity of the endogenous microRNA miR-29a-3p. In research concerning bronchopulmonary dysplasia (BPD) and associated pulmonary hypertension (BPD-PH), miR-29a-3p has been identified as a significantly upregulated biomarker in the tracheal aspirates of affected infants. The mimic is utilized in experimental models to investigate the miRNA's role in pulmonary vascular remodeling, specifically its ability to suppress the expression of Platelet-Derived Growth Factor Subunit A (PDGFA) and Angiopoietin-Like 4 (ANGPTL4) in pulmonary artery smooth muscle cells. By modulating these angiogenic and growth factor pathways, miR-29a-3p is thought to contribute to the pathogenesis of BPD-PH, making its mimic a critical tool for understanding the molecular mechanisms of neonatal lung disease.

Other names
microRNA-29a-3p mimicmicroRNA29a-3p mimicmicroRNA 29a-3p mimichsa-miR-29a-3p mimichsa-miR29a-3p mimichsa-miR 29a-3p mimic
02

Targets

IGF-1 (Insulin-like growth factor 1)MCL1 (Myeloid cell leukemia sequence 1)Platelet-derived growth factor subunit A (PDGFA) mRNAAKT3 (RAC-gamma serine/threonine-protein kinase)B7-H3PTEN (Phosphatase and tensin homolog deleted on chromosome ten)DNMT3A (DNA methyltransferase 3 alpha)Transforming growth factor beta signaling pathway componentsDNMT3B (DNA (cytosine-5)-methyltransferase 3B)ANGPTL4 (Angiopoietin-like 4)

Beyond the preview

Go deeper on miR-29a-3p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-29a-3p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call